UNIGE document Scientific Article
previous document  unige:141560  next document
add to browser collection

Remdesivir for severe covid-19: a clinical practice guideline

Rochwerg, Bram
Agarwal, Arnav
Zeng, Linan
Leo, Yee-Sin
Appiah, John Adabie
Bartoszko, Jessica
Brignardello-Petersen, Romina
show hidden authors show all authors [1 - 27]
Published in BMJ. 2020, vol. 370, p. m2924
Abstract What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020.
Keywords Adenosine Monophosphate/analogs & derivatives/therapeutic useAlanine/analogs & derivatives/therapeutic useAntiviral Agents/therapeutic useBetacoronavirus/isolation & purificationCoronavirus Infections/diagnosis/drug therapy/mortality/therapy/virologyGuideline AdherenceHumansLength of Stay/statistics & numerical dataNetwork Meta-AnalysisPandemicsPneumonia, Viral/diagnosis/mortality/therapy/virologyRandomized Controlled Trials as TopicRespiration, Artificial/statistics & numerical dataSeverity of Illness IndexTime FactorsTreatment Outcome
PMID: 32732352
Full text
Research group Groupe Perrier Arnaud (Médecine interne générale, de réhabilitation et de gériatrie) (585)
(ISO format)
ROCHWERG, Bram et al. Remdesivir for severe covid-19: a clinical practice guideline. In: BMJ (Clinical Research Edition), 2020, vol. 370, p. m2924. doi: 10.1136/bmj.m2924 https://archive-ouverte.unige.ch/unige:141560

109 hits



Deposited on : 2020-09-18

Export document
Format :
Citation style :